Erratum to: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial

被引：0
|
作者：
Serge Masson
Pietro Caironi
Caterina Fanizza
Ralf Thomae
Roberto Bernasconi
Andrea Noto
Roberto Oggioni
Giovanni Stefano Pasetti
Marilena Romero
Gianni Tognoni
Roberto Latini
Luciano Gattinoni
机构：
[1] IRCCS–Istituto di Ricerche Farmacologiche ‘‘Mario Negri’’,Department of Cardiovascular Research
[2] Università degli Studi di Milano,Dipartimento di Fisiopatologia Medico
[3] Fondazione IRCCS Ca’ Granda–Ospedale Maggiore Policlinico,Chirurgica e dei Trapianti, Fondazione IRCCS Ca’ Granda
[4] Fondazione Mario Negri Sud,Ospedale Maggiore Policlinico
[5] Mitsubishi Chemical Europe GmbH,Dipartimento di Anestesia, Rianimazione, ed Emergenza Urgenza
[6] Azienda Ospedaliera San Paolo,undefined
[7] Ospedale del Mugello,undefined
[8] Ospedale Civile S. Giovanni di Dio,undefined
来源：
Intensive Care Medicine | 2015年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1736 / 1736
相关论文
共 30 条
  • [21] DIAGNOSTIC AND PROGNOSTIC VALUE OF SOLUBLE CD14 SUBTYPE (SCD14-ST) IN EMERGENCY PATIENTS WITH EARLY SEPSIS USING THE NEW ASSAY PATHFAST PRESEPSIN
    Spanuth, E.
    Ebelt, H.
    Ivandic, B.
    Werdan, K.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S361 - S361
  • [22] Compared values of presepsin (sCD14-ST) and procalcitonin as early markers of outcome in severe sepsis and septic shock: a preliminary report from the Albumin Italian Outcome Sepsis (ALBIOS) study
    P Caironi
    S Masson
    E Spanuth
    R Thomae
    R Fumagalli
    A Pesenti
    M Romero
    G Tognoni
    R Latini
    L Gattinoni
    Critical Care, 17 (Suppl 2):
  • [23] Presepsin ( soluble CD14 subtype) Is Secreted from Human Monocytes after Phagocytosis - in Vitro Analyses and a Retrospective Cohort Study in Patients with Allogeneic Stem Cell Transplantation
    Arai, Yasuyuki
    Yamashita, Kouhei
    Mizugishi, Kiyomi
    Takaori-Kondo, Akifumi
    BLOOD, 2014, 124 (21)
  • [24] TLR2, TLR4, CD14, CD11b, and CD11c expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock
    Brunialti, MKC
    Martins, PS
    de Carvalho, HB
    Machado, FR
    Barbosa, LM
    Salomao, R
    SHOCK, 2006, 25 (04): : 351 - 357
  • [25] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial
    Abraham, E
    Glauser, MP
    Butler, T
    Garbino, J
    Gelmont, D
    Laterre, PF
    Kudsk, K
    Bruining, HA
    Otto, C
    Tobin, E
    Zwingelstein, C
    Lesslauer, W
    Leighton, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19): : 1531 - 1538
  • [26] The relationship between soluble CD73 and the incidence of septic shock in severe sepsis patients: a cross-sectional analysis of data from a prospective FINNAKI study
    Gao, Jun
    Chen, Shanglin
    Kong, Tianyu
    Wen, Deliang
    Yang, Qilin
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (06)
  • [27] Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trial
    Roggeveen, Luca F.
    Fleuren, Lucas M.
    Guo, Tingjie
    Thoral, Patrick
    de Grooth, Harm Jan
    Swart, Eleonora L.
    Klausch, Thomas L. T.
    van der Voort, Peter H. J.
    Girbes, Armand R. J.
    Bosman, Rob J.
    Elbers, Paul W. G.
    TRIALS, 2019, 20 (01)
  • [28] Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock — rationale and design of a multicenter randomized controlled superiority trial
    Luca F. Roggeveen
    Lucas M. Fleuren
    Tingjie Guo
    Patrick Thoral
    Harm Jan de Grooth
    Eleonora L. Swart
    Thomas L. T. Klausch
    Peter H. J. van der Voort
    Armand R. J. Girbes
    Rob J. Bosman
    Paul W. G. Elbers
    Trials, 20
  • [29] Host-derived Delta-like Canonical Notch ligand-1 in sepsis and septic shock: Infection site, pathogens and disease severity matter - Secondary analysis of data from a randomized controlled trial
    Theobald, Vivienne
    Bloos, Frank
    Bauer, Michael
    Brenner, Thorsten
    von der Forst, Maik
    Meybohm, Patrick
    Schenz, Judith
    Schmitt, Felix C. F.
    Siegler, Benedikt
    Weigand, Markus A.
    Dietrich, Maximilian
    JOURNAL OF INFECTION, 2025, 90 (04)
  • [30] Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients
    Abraham, E
    Laterre, PF
    Garbino, J
    Pingleton, S
    Butler, T
    Dugernier, T
    Margolis, B
    Kudsk, K
    Zimmerli, W
    Anderson, P
    Reynaert, M
    Lew, D
    Lesslauer, W
    Passe, S
    Cooper, P
    Burdeska, A
    Modi, M
    Leighton, A
    Salgo, M
    Van der Auwera, P
    CRITICAL CARE MEDICINE, 2001, 29 (03) : 503 - 510
123